NORTHWEST BIOTHERAPEUTICS INC Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Northwest Biotherapeutics Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Northwest Biotherapeutics Inc Debt-to-equity for the quarter ending June 30, 2024 was -111 %, a 0.4% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -111 -0.44 -0.4% Jun 30, 2024
Q1 2024 -109 +6.84 +5.89% Mar 31, 2024
Q4 2023 -110 +8.51 +7.17% Dec 31, 2023
Q3 2023 -108 +18.2 +14.4% Sep 30, 2023
Q2 2023 -111 +9.16 +7.64% Jun 30, 2023
Q1 2023 -116 -1.92 -1.68% Mar 31, 2023
Q4 2022 -119 -7.17 -6.43% Dec 31, 2022
Q3 2022 -126 -17.1 -15.7% Sep 30, 2022
Q2 2022 -120 -10.4 -9.45% Jun 30, 2022
Q1 2022 -114 -3.8 -3.44% Mar 31, 2022
Q4 2021 -111 +0.16 +0.14% Dec 31, 2021
Q3 2021 -109 +6.61 +5.72% Sep 30, 2021
Q2 2021 -109 +8.76 +7.41% Jun 30, 2021
Q1 2021 -110 +10.7 +8.8% Mar 31, 2021
Q4 2020 -112 +15.2 +12% Dec 31, 2020
Q3 2020 -116 +16.9 +12.8% Sep 30, 2020
Q2 2020 -118 +33.7 +22.2% Jun 30, 2020
Q1 2020 -121 +30.3 +20% Mar 31, 2020
Q4 2019 -127 +23.1 +15.4% Dec 31, 2019
Q3 2019 -132 +15.9 +10.7% Sep 30, 2019
Q2 2019 -152 -1.58 -1.05% Jun 30, 2019
Q1 2019 -151 +18.4 +10.8% Mar 31, 2019
Q4 2018 -150 +45.8 +23.4% Dec 31, 2018
Q3 2018 -148 +92.1 +38.3% Sep 30, 2018
Q2 2018 -150 +141 +48.3% Jun 30, 2018
Q1 2018 -170 +162 +48.8% Mar 31, 2018
Q4 2017 -196 +285 +59.3% Dec 31, 2017
Q3 2017 -240 +530 +68.8% Sep 30, 2017
Q2 2017 -291 +79.9 +21.5% Jun 30, 2017
Q1 2017 -332 -59.2 -21.7% Mar 31, 2017
Q4 2016 -480 -267 -126% Dec 31, 2016
Q3 2016 -770 -577 -300% Sep 30, 2016
Q2 2016 -371 -177 -91.6% Jun 30, 2016
Q1 2016 -272 Mar 31, 2016
Q4 2015 -213 Dec 31, 2015
Q3 2015 -193 Sep 30, 2015
Q2 2015 -194 Jun 30, 2015
Q4 2013 -86.3 +12.1 +12.3% Dec 31, 2013
Q3 2013 -73.4 +27.9 +27.5% Sep 30, 2013
Q2 2013 -79.8 +22.4 +21.9% Jun 30, 2013
Q1 2013 -88.9 +16.5 +15.7% Mar 31, 2013
Q4 2012 -98.4 Dec 31, 2012
Q3 2012 -101 Sep 30, 2012
Q2 2012 -102 Jun 30, 2012
Q1 2012 -105 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.